These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31022465)

  • 1. Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin/resveratrol and resveratrol/curcumin in ovarian cancer.
    Fatease AA; Shah V; Nguyen DX; Cote B; LeBlanc N; Rao DA; Alani AWG
    Nanomedicine; 2019 Jul; 19():39-48. PubMed ID: 31022465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.
    Cote B; Carlson LJ; Rao DA; Alani AWG
    J Control Release; 2015 Sep; 213():128-133. PubMed ID: 26160305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity.
    Carlson LJ; Cote B; Alani AW; Rao DA
    J Pharm Sci; 2014 Aug; 103(8):2315-22. PubMed ID: 24914015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.
    Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G
    J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles.
    Wang J; Ma W; Tu P
    Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier.
    Li H; Li M; Chen C; Fan A; Kong D; Wang Z; Zhao Y
    Int J Pharm; 2015 Nov; 495(1):572-578. PubMed ID: 26387617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of quercetin against adriamycin-induced cardiotoxicity and its mechanism in mice].
    Pei TX; Xu CQ; Li B; Zhang ZR; Gao XX; Yu J; Li HZ; Yang BF
    Yao Xue Xue Bao; 2007 Oct; 42(10):1029-33. PubMed ID: 18229606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity.
    Zhang L; Zhu K; Zeng H; Zhang J; Pu Y; Wang Z; Zhang T; Wang B
    Int J Nanomedicine; 2019; 14():6061-6071. PubMed ID: 31534336
    [No Abstract]   [Full Text] [Related]  

  • 9. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
    Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y
    Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer.
    Saxena V; Hussain MD
    J Biomed Nanotechnol; 2013 Jul; 9(7):1146-54. PubMed ID: 23909128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of curcumin, quercetin, or resveratrol on the pathophysiology of endometriosis: A systematic review.
    Hipólito-Reis M; Neto AC; Neves D
    Phytother Res; 2022 Jun; 36(6):2416-2433. PubMed ID: 35583746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin-Loaded Blood-Stable Polymeric Micelles for Enhancing Therapeutic Effect on Erythroleukemia.
    Gong F; Chen D; Teng X; Ge J; Ning X; Shen YL; Li J; Wang S
    Mol Pharm; 2017 Aug; 14(8):2585-2594. PubMed ID: 28199114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.
    Baghbani F; Moztarzadeh F
    Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets.
    Aras A; Khokhar AR; Qureshi MZ; Silva MF; Sobczak-Kupiec A; Pineda EA; Hechenleitner AA; Farooqi AA
    Asian Pac J Cancer Prev; 2014; 15(9):3865-71. PubMed ID: 24935565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer.
    Scarano W; de Souza P; Stenzel MH
    Biomater Sci; 2015 Jan; 3(1):163-74. PubMed ID: 26214199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities.
    Hu LF; Lan HR; Li XM; Jin KT
    Oxid Med Cell Longev; 2021; 2021():2951697. PubMed ID: 34471463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer.
    Gao X; Wang B; Wei X; Men K; Zheng F; Zhou Y; Zheng Y; Gou M; Huang M; Guo G; Huang N; Qian Z; Wei Y
    Nanoscale; 2012 Nov; 4(22):7021-30. PubMed ID: 23044718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin Reverses Altered Energy Metabolism in the Heart of Rats Receiving Adriamycin Chemotherapy.
    Zakaria N; Khalil SR; Awad A; Khairy GM
    Cardiovasc Toxicol; 2018 Apr; 18(2):109-119. PubMed ID: 28702745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ.
    He H; Luo Y; Qiao Y; Zhang Z; Yin D; Yao J; You J; He M
    Food Funct; 2018 Aug; 9(8):4404-4418. PubMed ID: 30063064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor.
    Yokoyama M; Fukushima S; Uehara R; Okamoto K; Kataoka K; Sakurai Y; Okano T
    J Control Release; 1998 Jan; 50(1-3):79-92. PubMed ID: 9685875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.